Yüklüyor......
Clinical predictors of extrapyramidal symptoms associated with aripiprazole augmentation for the treatment of late-life depression in a randomized controlled trial
OBJECTIVE: Augmentation with aripiprazole is an effective pharmacotherapy for treatment resistant late-life depression (TRLLD). However, aripirprazole can cause extrapyramidal symptoms (EPS) such as akathisia and parkinsonism; these symptoms are distressing and can contribute to treatment discontinu...
Kaydedildi:
| Yayımlandı: | J Clin Psychiatry |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6996023/ https://ncbi.nlm.nih.gov/pubmed/29924506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.17m11764 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|